You are here: Industry Insights > Diabetes

News List

Novo Nordisk trumpets more Januvia-topping data for oral semaglutide fiercepharma
July 02, 2018
Just eight days after posting a trial win over Merck diabetes stalwart Januvia, Novo Nordisk candidate semaglutide is back with another.
J&J agrees to sell LifeScan unit for $2.1B biospectrumasia
June 14, 2018
Johnson & Johnson accepted Platinum Equity's $2.1 billion offer for LifeScan, the company's blood glucose monitoring unit known for its OneTouch brand of glucose meters and insulin pumps.
Hydrogel could enable pancreatic islet transplants for diabetes fiercebiotech
June 11, 2018
Scientists searching for Type 1 diabetes cures have long been interested in transplanting functioning pancreatic islet cells into patients, but the danger of immune system rejection has been an obstacle.
New study shows increased risk for diabetic patients after shoulder replacement biospectrumasia
June 07, 2018
New research analyzes the association of preoperative blood sugar levels with an increased risk of wound complications and deep infection
Diabetes drugs show promise to treat symptoms of Alzheimer’s europeanpharmaceuticalreview
May 22, 2018
Discovery of a pathway linking Alzheimer’s disease and Type 2 diabetes leads to new strategies to preserve brain health…
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 08, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society have joined forces to find better solutions to alleviate the burden ...
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 03, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia...
A potential new weapon in the addiction battle: FDA-approved diabetes and obesity drugs worldpharmanews
May 02, 2018
Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.
Overseas Partnerships: Eli Lilly Forges Chinese Diabetes Collaboration biospace
April 26, 2018
China continues to be a hotbed of investment for U.S. pharmaceutical and biotech companies
Diabetes drug may not reduce risk of death europeanpharmaceuticalreview
April 19, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page